We are live on ! Find out more
MYGN icon

Myriad Genetics
MYGN

228 hedge funds and large institutions have $833M invested in Myriad Genetics in 2025 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 79 increasing their positions, 79 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

402% more call options, than puts

Call options by funds: $854K | Put options by funds: $170K

28% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 29

3% more funds holding

Funds holding: 221 → 228 (+7)

1.26% more ownership

Funds ownership: 101.59% → 102.85% (+1.3%)

0% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 79

34% less capital invested

Capital invested by funds: $1.27B → $833M (-$436M)

Holders
228
Holders Change
+7
Holders Change %
+3.17%
% of All Funds
3.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
37
Increased
79
Reduced
79
Closed
29
Calls
$854K
Puts
$170K
Net Calls
+$684K
Net Calls Change
-$3.13M

Top Buyers

Rank Fund Capital Flow
1
DGI
Disciplined Growth Investors
Minnesota
+$26.1M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$9.36M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$8.44M
4
PCM
Portolan Capital Management
Massachusetts
+$6.6M
5
Voloridge Investment Management
Voloridge Investment Management
Florida
+$5.08M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$17M
2
CCM
Camber Capital Management
Massachusetts
-$9.01M
3
Artisan Partners
Artisan Partners
Wisconsin
-$5.88M
4
Pictet Asset Management
Pictet Asset Management
Switzerland
-$5.6M
5
BlackRock
BlackRock
New York
-$5.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
CB
226
CNB Bank
Pennsylvania
$9 – – –
PCM
227
Peregrine Capital Management
Minnesota
– -$4.7M -342,845 Closed
HIM
228
Hillsdale Investment Management
Ontario, Canada
– -$2.28M -166,300 Closed
Arrowstreet Capital
229
Arrowstreet Capital
Massachusetts
– -$2.1M -153,062 Closed
First Trust Advisors
230
First Trust Advisors
Illinois
– -$1.91M -139,545 Closed
EIM
231
Essex Investment Management
Massachusetts
– -$1.6M -116,709 Closed
DB
232
Danske Bank
Denmark
– -$1.49M -108,641 Closed
TC
233
TwinBeech Capital
New York
– -$562K -40,975 Closed
LCM
234
Legato Capital Management
California
– -$479K -34,955 Closed
GCP
235
GSA Capital Partners
United Kingdom
– -$360K -26,236 Closed
CM
236
Caption Management
Oklahoma
– -$274K -20,000 Closed
AC
237
Aristides Capital
Kentucky
– -$199K -14,500 Closed
ET
238
Entropy Technologies
New York
– -$178K -12,998 Closed
SC
239
Syon Capital
California
– -$176K -12,856 Closed
American Century Companies
240
American Century Companies
Missouri
– -$172K -12,565 Closed
CFGS
241
Concourse Financial Group Securities
Alabama
– -$52.1K -4,240 Closed
MFG
242
Menard Financial Group
Texas
– -$16K -1,165 Closed
Northwestern Mutual Wealth Management
243
Northwestern Mutual Wealth Management
Wisconsin
– -$9.2K -671 Closed
UB
244
UMB Bank
Missouri
– -$3.48K -254 Closed
QL
245
Quarry LP
New York
– -$2.47K -180 Closed
RS
246
R Squared
Hong Kong
– -$1.84K -134 Closed
PA
247
Pineridge Advisors
Missouri
– -$727 -53 Closed
CA
248
CoreCap Advisors
Michigan
– -$466 -34 Closed
T
249
Transce3nd
Texas
– -$137 -10 Closed
DPW
250
DiNuzzo Private Wealth
Pennsylvania
– -$42 -3 Closed
7 8 9
10
11

MYGN Hedge Fund Activity: Q1 2025 in Review

228 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Myriad Genetics (MYGN) for Q1 2025, worth a combined $833M — down 34% from $1.27B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new MYGN positions and 29 closed out — a net gain of 8 holders — while 79 added to existing stakes and 79 trimmed.

The largest buyer was Disciplined Growth Investors, adding an estimated $26.1M. The largest seller was Wellington Management Group, cutting an estimated $17M.

  • 228 institutional investors held Myriad Genetics (MYGN) as of Q1 2025, up from 221 in Q4 2024.
  • Funds reported $833M of Myriad Genetics stock for Q1 2025, down 34% quarter-over-quarter.
  • 37 funds opened new Myriad Genetics positions in Q1 2025 and 29 closed out, a net change of +8 holders.
  • The largest Myriad Genetics buyer in Q1 2025 was Disciplined Growth Investors, an estimated $26.1M added.
  • The largest Myriad Genetics seller in Q1 2025 was Wellington Management Group, an estimated $17M sold.

Based on aggregated 13F filings for Q1 2025.